Senya Therapeutics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$555K
- Investors
-
8
Senya Therapeutics General Information
Description
Developer of biologics intended for unmet clinical needs in nephrology, oncology, ophthalmology, and other indications. The company utilizes antibody-based products against a protein target that promotes vascular destabilization and uninhibited blood-vessel formation in pathology, enabling medical staff & doctors to normalize and improve the vascularization of solid tumors with penetration and improved efficacy for small molecules, biologics, and cell therapies.
Contact Information
Website
www.senyatx.comCorporate Office
- 90 Tottenham Court Road
- London W1T 4TJ
- England, United Kingdom
Corporate Office
- 90 Tottenham Court Road
- London W1T 4TJ
- England, United Kingdom
Senya Therapeutics Timeline
Senya Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Seed Round | 04-Feb-2026 | $555K | Completed | Startup | ||
| 4. Seed Round | 01-Jun-2024 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 04-Jan-2024 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 03-May-2019 | $716K | $716K | Completed | Startup | |
| 1. University Spin-Out | 08-Feb-2019 | Completed | Startup |
Senya Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed Preferred | ||||||||
| Seed Preferred | ||||||||
| Seed Preferred | 173,333 | $0.000001 | $1.22 | $1.22 | 1x | $1.22 | 3.58% | |
| B Ordinary | 550,000 | $0.000001 | $1.35 | $1.35 | 1x | $1.35 | 11.37% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Senya Therapeutics Patents
Senya Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202502132-D0 | Therapeutic | Inactive | 13-Feb-2025 |
Senya Therapeutics Signals
Senya Therapeutics Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AlbionVC | Venture Capital | Minority | ||
| Cambridge Technology Capital Fund | Mezzanine | Minority | ||
| Cancer Research Technology | Venture Capital | Minority | ||
| NG Bio (UK) | Venture Capital | Minority | ||
| UCL Technology Fund | Venture Capital | Minority |
Senya Therapeutics FAQs
-
When was Senya Therapeutics founded?
Senya Therapeutics was founded in 2019.
-
Where is Senya Therapeutics headquartered?
Senya Therapeutics is headquartered in London, United Kingdom.
-
What is the size of Senya Therapeutics?
Senya Therapeutics has 2 total employees.
-
What industry is Senya Therapeutics in?
Senya Therapeutics’s primary industry is Drug Discovery.
-
Is Senya Therapeutics a private or public company?
Senya Therapeutics is a Private company.
-
What is the current valuation of Senya Therapeutics?
The current valuation of Senya Therapeutics is .
-
What is Senya Therapeutics’s current revenue?
The current revenue for Senya Therapeutics is .
-
How much funding has Senya Therapeutics raised over time?
Senya Therapeutics has raised $3.55M.
-
Who are Senya Therapeutics’s investors?
AlbionVC, Cambridge Technology Capital Fund, Cancer Research Technology, NG Bio (UK), and UCL Technology Fund are 5 of 8 investors who have invested in Senya Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process